多巴胺类药物调节人类的恐惧灭绝相关过程,但效果是温和的
Alice Doubliez1, Kristina Köster1, Lara Müntefering1
1Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Essen University Hospital, University of Duisburg-Essen, 45147 Essen, Germany.
Brain communications
|September 22, 2025
概括
多巴胺药物影响恐惧的灭绝. 作为多巴胺激动剂的布罗莫克里在人类中加速了恐惧灭绝的回忆,这表明多巴胺系统有助于记忆巩固.
科学领域:
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
- 行为科学 行为科学
背景情况:
- 恐惧灭绝对于适应性行为至关重要.
- 半边缘多巴胺系统涉及到奖励和潜在的恐惧灭绝学习.
- 意外遗漏的厌恶刺激作为奖励,驱动灭绝.
研究的目的:
- 调查多巴胺类药物是否促进或阻碍人类恐惧灭绝学习.
- 为了测试多巴胺激动剂增强和对抗剂损害灭绝的假设.
主要方法:
- 146名健康参与者接受了为期3天的差异性恐惧调节范式.
- 记录了瞳孔大小和皮肤导电性反应 (SCRs).
- 在灭绝训练之前,参与者接受了多巴胺激动剂 (莱沃多巴,烯) 或抗剂 (蒂亚普里德,利) 或安慰剂.
主要成果:
- 观察到的效果很小,主要是在布罗莫克里普丁组.
- 布罗莫克里因导致在回忆过程中瞳孔扩张减少,这表明恐惧重新灭绝的速度更快.
- 利沃多巴和哈洛佩里多尔显示出非特异性作用或副作用.
结论:
- 这些发现支持多巴胺系统在人类恐惧灭绝中的作用.
- 多巴胺激素药物,特别是布罗莫克里普丁等激动剂,可能会增强恐惧灭绝记忆巩固.
相关概念视频
01:29Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
01:26Anxiolytic Drugs: Overview
1.1K
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
1.1K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
01:20Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K
01:25Adrenergic Agonists: Indirect-Acting Agents
2.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.6K
01:17Classical Conditioning in Daily Life
2.1K
Classical conditioning, a fundamental principle of associative learning, explains various phenomena observed in daily life, such as fear development, the placebo effect, taste aversion, and drug habituation. These applications demonstrate the profound impact of associative learning on human behavior and physiological responses.
John B. Watson and Rosalie Rayner famously demonstrated the development of fear through classical conditioning in their experiment with Little Albert. They paired the...
John B. Watson and Rosalie Rayner famously demonstrated the development of fear through classical conditioning in their experiment with Little Albert. They paired the...
2.1K